These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38601677)

  • 1. Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure.
    Kazemi Asl S; Rahimzadegan M; Kazemi Asl A
    Heliyon; 2024 Apr; 10(7):e28983. PubMed ID: 38601677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Medicine in Cancer Pain Management.
    Raad M; López WOC; Sharafshah A; Assefi M; Lewandrowski KU
    J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing in individuals with multiple cardiovascular risk factors and normal coronary arteries.
    Abramowitz Y; Roth A; Keren G; Isakov O; Shomron N; Laitman Y; Weissglas-Volkov D; Arbel Y; Banai S; Finkelstein A; Friedman E
    Coron Artery Dis; 2016 Jun; 27(4):257-66. PubMed ID: 26905423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actionable Pharmacogenetic Variation in the Slovenian Genomic Database.
    Hočevar K; Maver A; Peterlin B
    Front Pharmacol; 2019; 10():240. PubMed ID: 30930780
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare and common coding variants in lipid metabolism-related genes and their association with coronary artery disease.
    Li W; Wang Y; Huang R; Lian F; Xu G; Wang W; Xue S
    BMC Cardiovasc Disord; 2024 Feb; 24(1):97. PubMed ID: 38336686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
    Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
    Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.
    Tada H; Kawashiri MA; Nohara A; Saito R; Tanaka Y; Nomura A; Konno T; Sakata K; Fujino N; Takamura T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2015 Jun; 240(2):324-9. PubMed ID: 25875382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
    Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
    Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
    Parada-Márquez JF; Maldonado-Rodriguez ND; Triana-Fonseca P; Contreras-Bravo NC; Calderón-Ospina CA; Restrepo CM; Morel A; Ortega-Recalde OJ; Silgado-Guzmán DF; Angulo-Aguado M; Fonseca-Mendoza DJ
    Front Pharmacol; 2023; 14():1047854. PubMed ID: 37021041
    [No Abstract]   [Full Text] [Related]  

  • 12. Computational pharmacogenotype extraction from clinical next-generation sequencing.
    Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
    Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities.
    Wang D; Bolleddula J; Coenen-Stass A; Grombacher T; Dong JQ; Scheuenpflug J; Locatelli G; Feng Z
    Pharmacogenomics; 2024 Mar; 25(4):197-206. PubMed ID: 38511470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis.
    Duan S; Luo X; Dong C
    Gene; 2013 Dec; 531(2):347-54. PubMed ID: 23994195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study.
    Vizirianakis IS; Chatzopoulou F; Papazoglou AS; Karagiannidis E; Sofidis G; Stalikas N; Stefopoulos C; Kyritsis KA; Mittas N; Theodoroula NF; Lampri A; Mezarli E; Kartas A; Chatzidimitriou D; Papa-Konidari A; Angelis E; Karvounis Η; Sianos G
    BMC Cardiovasc Disord; 2021 Jun; 21(1):284. PubMed ID: 34103005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Next-Generation Sequencing in Pharmacogenomics.
    Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Exome Sequencing to Identify Genetic Variants Associated with Raised Atherosclerotic Lesions in Young Persons.
    Hixson JE; Jun G; Shimmin LC; Wang Y; Yu G; Mao C; Warren AS; Howard TD; Heide RSV; Van Eyk J; Wang Y; Herrington DM
    Sci Rep; 2017 Jun; 7(1):4091. PubMed ID: 28642624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine.
    Salleh MZ; Teh LK; Lee LS; Ismet RI; Patowary A; Joshi K; Pasha A; Ahmed AZ; Janor RM; Hamzah AS; Adam A; Yusoff K; Hoh BP; Hatta FH; Ismail MI; Scaria V; Sivasubbu S
    PLoS One; 2013; 8(8):e71554. PubMed ID: 24009664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.
    McConnell H; Andrews TD; Field MA
    PeerJ; 2021; 9():e11774. PubMed ID: 34316407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.